Squarepoint
EOLS icon

Squarepoint’s Evolus EOLS Stock Holding History

Squarepoint’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,000
Closed -$350K – 4203
2024
Q1 		$350K Buy
+25,000
New +$325K ﹤0.01% 3287

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's EOLS Position: Q1 2026 in Review

Squarepoint reduced its Evolus (EOLS) stake by 9.2% in Q1 2026, selling an estimated $77.3K and leaving 158,392 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #3122.

Squarepoint first reported a position in EOLS in Q3 2018 and has held it in 22 quarters since. The position peaked at $2.58M in Q3 2023. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Squarepoint held 158,392 shares of Evolus worth $651K as of Q1 2026.
  • Squarepoint sold 15,954 Evolus shares in Q1 2026, an estimated $77.3K.
  • Evolus made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3122 holding.
  • Squarepoint first reported a position in Evolus in Q3 2018 and has held it in 22 quarters since.
  • Squarepoint's Evolus position peaked at $2.58M in Q3 2023.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.